Clinical Trial

Efficacy and Safety of Intravitreal Injection of Bevacizumab with and Without Oral Curcumin

Recruiting Phase 2/3
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2024 (before its estimated September 22, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to evaluate the effectiveness of adding curcumin oral treatment to bevacizumab intravitreal injection in patients with central macular edema. A blind study and a randomized and controlled clinical trial are conducted on diabetic patients with macular edema. The patients are divided into two intervention groups (bevacizumab + curcumin) and control (bevacizumab + placebo). The evaluation of the central thickness of the macula and the evaluation of the central volume of the macula are the primary goals and the evaluation of the best visual acuity of the patient is the secondary goal.
Trial Details
NCT Number NCT06595355
Lead Sponsor Isfahan University of Medical Sciences
Conditions Diabetic Macular Edema, Macular Edema, Retinal Neovascularization
Enrollment 52 participants
Start Date 2021-10-10
Primary Completion 2025-09-22 (estimated)
Study Completion 2025-09-22 (estimated)
Updated on ClinicalTrials.gov 2024-09-19